Pathologic Observations in Human Allograft Recipients Treated with FK 506

Overview

Journal Transplant Proc

Specialty General Surgery

Date 1990 Feb 1

PMID 1689891

Citations 18

Authors

A J Demetris

J J Fung

S Todo

B Banner

T Zerbe

G Sysyn

T E Starzl

Affiliations

Soon will be listed here.

Citing Articles

Protective effect of silymarin on tacrolimus-induced kidney and liver toxicity.

Terzi F, Ciftci M BMC Complement Med Ther. 2022; 22(1):331.

PMID: 36514062 PMC: 9746137. DOI: 10.1186/s12906-022-03803-x.

Clinicopathologic Characteristics of Centrilobular Injury in Pediatric Liver Transplantation.

Gonzalez I, Lu H, Alipour Z, Kulkarni S, Stoll J, Liss K Liver Transpl. 2020; 27(3):416-424.

PMID: 33253466 PMC: 10619582. DOI: 10.1002/lt.25958.

FKBP Ligands-Where We Are and Where to Go?.

Kolos J, Voll A, Bauder M, Hausch F Front Pharmacol. 2018; 9:1425.

PMID: 30568592 PMC: 6290070. DOI: 10.3389/fphar.2018.01425.

Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging.

Blakolmer K, Jain A, Ruppert K, Gray E, Duquesnoy R, Murase N Transplantation. 2000; 69(11):2330-6.

PMID: 10868635 PMC: 2967190. DOI: 10.1097/00007890-200006150-00019.

Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

Demetris A, Murase N, Lee R, Randhawa P, Zeevi A, Pham S Ann Transplant. 1997; 2(2):27-44.

PMID: 9869851 PMC: 3235804.

References

Murase N, Todo S, Lee P, Lai H, Chapman F, Nalesnik M . Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc. 1987; 19(5 Suppl 6):71-5. PMC: 2903833. View

Ochiai T, Nakajima K, Nagata M, Hori S, Asano T, Isono K . Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats. Transplantation. 1987; 44(6):734-8. DOI: 10.1097/00007890-198712000-00002. View

Todo S, Demetris A, Ueda Y, Imventarza O, Cadoff E, Zeevi A . Renal transplantation in baboons under FK 506. Surgery. 1989; 106(2):444-50; discussion 450-1. View

Thiru S, Collier D, Calne R . Pathological studies in canine and baboon renal allograft recipients immunosuppressed with FK-506. Transplant Proc. 1987; 19(5 Suppl 6):98-9. View

Nalesnik M, Todo S, Murase N, Gryzan S, Lee P, Makowka L . Toxicology of FK-506 in the Lewis rat. Transplant Proc. 1987; 19(5 Suppl 6):89-92. PMC: 2903834. View

Todo S, Demetris A, Ueda Y, Imventarza O, Okuda K, Casavilla A . Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc. 1987; 19(5 Suppl 6):57-61. PMC: 2903874. View

Ochiai T, Sakamoto K, Gunji Y, Hamaguchi K, Isegawa N, Suzuki T . Effects of combination treatment with FK506 and cyclosporine on survival time and vascular changes in renal-allograft-recipient dogs. Transplantation. 1989; 48(2):193-7. DOI: 10.1097/00007890-198908000-00003. View

Todo S, Ueda Y, Demetris J, Imventarza O, Nalesnik M, Venkataramanan R . Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery. 1988; 104(2):239-49. PMC: 2972580. View

Kerns W, Arena E, Morgan D . Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat. Am J Pathol. 1989; 135(2):339-49. PMC: 1879911. View

10.

Inamura N, Nakahara K, Kino T, Goto T, Aoki H, Yamaguchi I . Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK506. Transplantation. 1988; 45(1):206-9. DOI: 10.1097/00007890-198801000-00042. View

11.

Collier D, Thiru S, Calne R . Kidney transplantation in the dog receiving FK-506. Transplant Proc. 1987; 19(5 Suppl 6):62. View

12.

Snover D, Sibley R, Freese D, Sharp H, Bloomer J, Najarian J . Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology. 1984; 4(6):1212-22. DOI: 10.1002/hep.1840040620. View

13.

Foster P, Sankary H, Hart M, Ashmann M, Williams J . Blood and graft eosinophilia as predictors of rejection in human liver transplantation. Transplantation. 1989; 47(1):72-4. DOI: 10.1097/00007890-198901000-00016. View

14.

Lim S, Thiru S, White D . Heterotopic heart transplantation in the rat receiving FK-506. Transplant Proc. 1987; 19(5 Suppl 6):68-70. View

15.

IREY N . Teaching monograph. Tissue reactions to drugs. Am J Pathol. 1976; 82(3):613-47. PMC: 2032418. View

16.

Williams J, Peters T, Vera S, Britt L, Van Voorst S, Haggitt R . Biopsy-directed immunosuppression following hepatic transplantation in man. Transplantation. 1985; 39(6):589-96. DOI: 10.1097/00007890-198506000-00003. View

17.

Calne R, Collier D, Thiru S . Observations about FK-506 in primates. Transplant Proc. 1987; 19(5 Suppl 6):63. View

18.

Zafrani E, Ishak K, Rudzki C . Cholestatic and hepatocellular injury associated with erythromycin esters: report of nine cases. Dig Dis Sci. 1979; 24(5):385-96. DOI: 10.1007/BF01297126. View

19.

Demetris A, Qian S, Sun H, Fung J . Liver allograft rejection: an overview of morphologic findings. Am J Surg Pathol. 1990; 14 Suppl 1:49-63. View

20.

Billingham M . Some recent advances in cardiac pathology. Hum Pathol. 1979; 10(4):367-86. DOI: 10.1016/s0046-8177(79)80043-x. View